Barco NV (0KDK)

22.890
0.000(0.00%)
  • Volume:
    27,889
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    22.890 - 22.890

0KDK Overview

Prev. Close
22.89
Day's Range
22.89-22.89
Revenue
-
Open
21.44
52 wk Range
17.32-25.7
EPS
0.31
Volume
27,889
Market Cap
1.95B
Dividend (Yield)
0.28
(1.29%)
Average Volume (3m)
53,425
P/E Ratio
71.53
Beta
1.41
1-Year Change
0%
Shares Outstanding
89,137,573
Next Earnings Date
18 Oct 2022
What is your sentiment on Barco?
or
Market is currently closed. Voting is open during market hours.

Barco NV News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Barco NV Company Profile

Barco NV Company Profile

Barco NV is a Belgium-based technology company, which specializes in the design and development of professional visualization equipment and solutions. The Company offers its products in such operating segments as Entertainment (primarily active in the field of Digital Cinema), Enterprise (including the Control Rooms and the Corporate activity) and Healthcare (dedicated to the high-resolution visualization segments of radiology and mammography and Internet protocol IP-connectivity solutions for the surgical room). The Company's products range includes display monitors, projectors, video walls, image processing and connectivity and interactivity software. The Company is active in Europe and the Middle East, North and South America, Africa and Asia.

Read More

Analyst Price Target

Average24.560 (+12.15% Upside)
High27
Low21
Price21.9
No. of Analysts5
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyStrong BuyStrong SellBuy
Technical IndicatorsStrong BuyBuyStrong BuySellStrong Buy
SummaryStrong BuyBuyStrong BuyStrong SellStrong Buy
  • I’m curious what people think. It’s no surprise Barco suffers under COVID work from home trend (meeting room tech) and no big events being organized (screens and projectors). But it’s hard to imagine these markets not returning as well as they have an interesting healthcare arm. Thoughts anyone?
    1
    • It is just a bad company to invest in
      0
    • Why?
      0